CoChat

Identification of a bacteriocin-like compound from Lactobacillus plantarum with antimicrobial activity and effects on normal and cancerogenic human intestinal cells

Open access
De Giani, Alessandra, Bovio, Federica, Forcella, Matilde, Fusi, Paola, Sello, Guido, Di Gennaro, Patrizia · 2019 · AMB Express

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index; none of the 16 sources its claims cite is checked for support yet.

Abstract

In this paper, we demonstrate that the antimicrobial activity of L. plantarum PBS067 strain against antagonist microorganisms was mediated by the production of a bacteriocin-like compound secreted at the stationary phase of the growth. The novel bacteriocin-like compound, designed plantaricin P1053, was identified by using sorption-desorption method, butanol extraction and SEC-HPLC. The molecular mass of plantaricin P1053 was shown to be 1053 Da by ESI-MS analysis. Plantaricin P1053 exhibited a broad-spectrum antimicrobial activity against Gram-positive bacteria as S. aureus and Gram-negative bacteria as E. coli. In addition to the antimicrobial activity, the isolated bacteriocin-like compound showed effects on normal and cancerogenic epithelial intestinal cell lines through an enhancing of viability of healthy cells and a proliferation reduction of cancer cells. Moreover, in this paper we demonstrate that the isolated bacteriocin-like compound acts on healthy cells through the epidermal growth factor receptor (EGFR) pathways. In conclusion, plantaricin P1053 isolated from L. plantarum PBS067 strain could represent one of the first multifunctional bacteriocin-like compound acting on human epithelial intestinal cells.

Overview

CoChat Summary

## TL;DR

The paper identifies a 1053 Da bacteriocin-like compound from *Lactobacillus plantarum* PBS067, named plantaricin P1053, that inhibits both Gram-positive and Gram-negative bacteria. It also reports opposite effects on intestinal cell lines: about a 20% increase in healthy CCD 841 cell viability and a significant, near-30% reduction in E705 colon cancer cell viability.

## Key findings

  • *L. plantarum* PBS067 produced antimicrobial activity in stationary phase; the cell-free supernatant inhibited E. coli with a halo of 18 mm ± 0.2 and S. aureus with 20 mm ± 0.2.
  • The purified compound, plantaricin P1053, had a molecular mass of 1053 Da by ESI-MS and retained antimicrobial activity after purification.
  • Plantaricin P1053 showed broad antimicrobial activity against E. coli and S. aureus; reported MICs were 7.8 µg/mL for E. coli ATCC 25922 and 31 µg/mL for S. aureus ATCC 6538.
  • On human intestinal cells, 1 µg/mL plantaricin P1053 increased healthy CCD 841 cell viability by about 20%, while on E705 colon cancer cells it caused a significant inhibitory effect, near 30%, in a concentration-dependent manner.

## Methods

  • The study used *L. plantarum* PBS067 isolated from healthy human feces; antimicrobial assays were performed against E. coli, S. aureus, P. aeruginosa, and E. faecalis using a well diffusion agar assay.
  • The bacteriocin-like compound was purified from culture supernatant by adsorption/desorption, n-butanol extraction, and SEC-HPLC, then characterized by ESI-full mass spectrometry.
  • Effects on host cells were tested in CCD 841 healthy colon cells and E705 colon cancer cells using MTT viability assays and western blotting for EGFR/Akt/Erk signaling after treatment with 1 µg/mL plantaricin P1053.

## Limitations

  • The paper states that “some molecular mechanisms must be elucidated in further studies”, so the pathway for the cancer-cell effect is not fully explained.
  • The text makes evident that the EGFR/Akt/Erk work is based on in vitro cell lines only; no in vivo or clinical validation is reported.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1186/s13568-019-0813-6

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Antimicrobial activity of Lactobacillus plantarum PBS067 cell free supernatant. The antimicrobial activity of L. plantarum PBS607 cell free supernatant (CFS) was determined as halo of growth inhibition of E. coli ATCC 25922 through the agar well diffusion assay. The figure shows the inhibition zones produced by CFS (A), by neutralized-acidified CFS (B), not inoculated MRS at pH 4 (C), not inoculated MRS (D) against E. coli ATCC 25922
Fig. 1 Antimicrobial activity of Lactobacillus plantarum PBS067 cell free supernatant. The antimicrobial activity of L. plantarum PBS607 cell free supernatant (CFS) was determined as halo of growth inhibition of E. coli ATCC 25922 through the agar well diffusion assay. The figure shows the inhibition zones produced by CFS (A), by neutralized-acidified CFS (B), not inoculated MRS at pH 4 (C), not inoculated MRS (D) against E. coli ATCC 25922CC BY · PubMed Central
Fig. 2 Step-by-step purification and antimicrobial activity of the bacteriocin-like compound. The antimicrobial activity of the purified extract was verified through agar well diffusion assay. Step 1 of purification and inhibition halo produced by the crude extract obtained after adsorption/desorption method (A), step 2 of purification and antimicrobial activity of the partial purified extract through an extraction with n-butyl alcohol (B), step 3 of purification and the growth inhibition of the eluted bacteriocin-like compound (C). All samples were tested against E. coli ATCC 25922
Fig. 2 Step-by-step purification and antimicrobial activity of the bacteriocin-like compound. The antimicrobial activity of the purified extract was verified through agar well diffusion assay. Step 1 of purification and inhibition halo produced by the crude extract obtained after adsorption/desorption method (A), step 2 of purification and antimicrobial activity of the partial purified extract through an extraction with n-butyl alcohol (B), step 3 of purification and the growth inhibition of the eluted bacteriocin-like compound (C). All samples were tested against E. coli ATCC 25922CC BY · PubMed Central
Fig. 3 Effect of proteinase K on the purified bacteriocin-like compound. The antimicrobial activity of the purified bacteriocin-like compound was determined as halo of growth inhibition of E. coli ATCC 25922 through the agar well diffusion assay. The Figure shows the lack of inhibition zone produced by the treatment of the bacteriocin-like compound by proteinase K (A); the inhibition halo produced by the no-treated bacteriocin-like compound after incubation at 37 °C and pH 7.5 (the proteinase K optimal pH) (B); the inhibition zone produced by the untreated bacteriocin-like compound at pH 2 (its optimal pH), as a positive control of the test (C); the lack of inhibition halo produced by the negative control NaCl 0.1 M pH 7.5 (buffer of the reaction with proteinase K) (D); and the lack of inhibition halo produced by the negative control NaCl 0.1M pH 2 (buffer for bacteriocin-like molecule activity) (E)
Fig. 3 Effect of proteinase K on the purified bacteriocin-like compound. The antimicrobial activity of the purified bacteriocin-like compound was determined as halo of growth inhibition of E. coli ATCC 25922 through the agar well diffusion assay. The Figure shows the lack of inhibition zone produced by the treatment of the bacteriocin-like compound by proteinase K (A); the inhibition halo produced by the no-treated bacteriocin-like compound after incubation at 37 °C and pH 7.5 (the proteinase K optimal pH) (B); the inhibition zone produced by the untreated bacteriocin-like compound at pH 2 (its optimal pH), as a positive control of the test (C); the lack of inhibition halo produced by the negative control NaCl 0.1 M pH 7.5 (buffer of the reaction with proteinase K) (D); and the lack of inhibition halo produced by the negative control NaCl 0.1M pH 2 (buffer for bacteriocin-like molecule activity) (E)CC BY · PubMed Central
Fig. 4 Analysis of the bacteriocin-like compound by mass spectrometry. Full scan mass spectrum of the extract in positive ESI ion detection mode with one main fragment showing m/z = 1053.05 Da. ITMS + c HESI E full MS (1.16 e4). The area around the M+ is enlarged in the insert
Fig. 4 Analysis of the bacteriocin-like compound by mass spectrometry. Full scan mass spectrum of the extract in positive ESI ion detection mode with one main fragment showing m/z = 1053.05 Da. ITMS + c HESI E full MS (1.16 e4). The area around the M+ is enlarged in the insertCC BY · PubMed Central
Fig. 5 Antimicrobial spectrum activity of plantaricin P1053. The antimicrobial spectrum activity of the plantaricin P1053 was verified through the inhibition growth halo in the agar well diffusion assay. The first panel shows the inhibition haloes against E. coli ATCC 25922 and the second panel against S. aureus ATCC 6538 produced by the plantaricin P1053 at neutral pH (A), by the plantaricin P1053 at pH 2 (B), by the NaCl 0.1 M at pH 2 (C) and by NaCl 0.1 M at pH 6.5 (D) as negative controls
Fig. 5 Antimicrobial spectrum activity of plantaricin P1053. The antimicrobial spectrum activity of the plantaricin P1053 was verified through the inhibition growth halo in the agar well diffusion assay. The first panel shows the inhibition haloes against E. coli ATCC 25922 and the second panel against S. aureus ATCC 6538 produced by the plantaricin P1053 at neutral pH (A), by the plantaricin P1053 at pH 2 (B), by the NaCl 0.1 M at pH 2 (C) and by NaCl 0.1 M at pH 6.5 (D) as negative controlsCC BY · PubMed Central
Fig. 6 Evaluation of cell viability on normal CCD 841 cell line after treatment with plantaricin P1053. MTT test was performed on normal CCD 841 cell line. Buffer NaCl 0.1 M pH 2 was used as control and it did not have any effect on cell viability. Values are presented as mean ± SD. Statistical analyses were performed using the Student’s t-test. *p < 0.05
Fig. 6 Evaluation of cell viability on normal CCD 841 cell line after treatment with plantaricin P1053. MTT test was performed on normal CCD 841 cell line. Buffer NaCl 0.1 M pH 2 was used as control and it did not have any effect on cell viability. Values are presented as mean ± SD. Statistical analyses were performed using the Student’s t-test. *p < 0.05CC BY · PubMed Central
Fig. 7 Western blotting analysis of EGFR pathway activation after exposure to plantaricin P1053 in CCD 841 cell line. Representative western blotting analyses performed on crude extracts, using anti-P-AKT, anti-AKT, anti-P-ERK1/2, anti-ERK1/2 and anti-GAPDH antibodies. GAPDH was used as a control. The experiments were performed in triplicate (a). Densitometric analysis performed with Scion Image Software. Values are expressed by comparing the data obtained after the treatment with plantaricin P1053 with those obtained from 0’ of exposition to the compound (b). Values are presented as mean ± SD. ND, no protein phosphorylation was detected
Fig. 7 Western blotting analysis of EGFR pathway activation after exposure to plantaricin P1053 in CCD 841 cell line. Representative western blotting analyses performed on crude extracts, using anti-P-AKT, anti-AKT, anti-P-ERK1/2, anti-ERK1/2 and anti-GAPDH antibodies. GAPDH was used as a control. The experiments were performed in triplicate (a). Densitometric analysis performed with Scion Image Software. Values are expressed by comparing the data obtained after the treatment with plantaricin P1053 with those obtained from 0’ of exposition to the compound (b). Values are presented as mean ± SD. ND, no protein phosphorylation was detectedCC BY · PubMed Central
Fig. 8 Evaluation of cell viability on E705 cancer colon cell line after treatment with plantaricin P1053. MTT test was performed on cancerogenic E705 cell line. Buffer NaCl 0.1 M pH 2 was used as control and it did not have any effect on cell viability (100% viability). Values are presented as mean ± SD. Statistical analyses were performed using the Student’s t-test. *p < 0.05
Fig. 8 Evaluation of cell viability on E705 cancer colon cell line after treatment with plantaricin P1053. MTT test was performed on cancerogenic E705 cell line. Buffer NaCl 0.1 M pH 2 was used as control and it did not have any effect on cell viability (100% viability). Values are presented as mean ± SD. Statistical analyses were performed using the Student’s t-test. *p < 0.05CC BY · PubMed Central

Verification

Claims the paper makes

0 Valid · 0 Not valid · 13 Not checked · 35 Own results and interpretations

29 more claims

Create a free account to see all 48 claims and to verify the 16 references still open.

See all claims — free account
  • It may state two separate claims as one. 11
  • Probably not a substantial claim. 5

Create a free account to see these claims.

Citations

Cites

Show all 30 references

Cited by

See all 88

Metadata

Authors
De Giani, A., Bovio, F., Forcella, M., Fusi, P., Sello, G., & Di Gennaro, P.
Affiliations
  • University of Milano-Bicocca (IT)
  • University of Milan (IT)
Venue
AMB Express
Published
2019-06-17
Volume
9
Issue
1
Pages
88-88
ISSN
2191-0855 (ISSN-L)
OpenAlex
W2951979851
Cited by
88
References
31
Citations by year
2026: 7 · 2025: 11 · 2024: 14 · 2023: 17 · 2022: 14 · 2021: 12 · 2020: 13
FWCI
7.52
Type
journal article
Language
en
Open access
Licence
Locations
  • AMB Express (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by)
  • BOA (University of Milano-Bicocca) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Regione Lombardia
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
  • Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
Keywords
Lactobacillus plantarum, antimicrobial activity, broad-spectrum antibacterial activity, Gram-positive bacteria, Gram-negative bacteria, intestinal epithelial cells, tumor cell proliferation, EGFR signaling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Identification of a bacteriocin-like compound from Lactobacillus plantarum with antimicrobial activity and effects on normal and cancerogenic human intestinal cells. https://app.cochat.ai/papers/10.1186/s13568-019-0813-6
The paper
De Giani, A., Bovio, F., Forcella, M., Fusi, P., Sello, G., & Di Gennaro, P. (2019). Identification of a bacteriocin-like compound from Lactobacillus plantarum with antimicrobial activity and effects on normal and cancerogenic human intestinal cells. AMB Express. https://doi.org/10.1186/s13568-019-0813-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.